Xeris Biopharma Holdings
XERS
XERS
54 hedge funds and large institutions have $128M invested in Xeris Biopharma Holdings in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.07% less ownership
Funds ownership: 66.37% → 65.31% (-1.1%)
27% less capital invested
Capital invested by funds: $176M → $128M (-$48.1M)
Holders
54
Holding in Top 10
–
Calls
$194K
Puts
$2K
Top Buyers
| 1 | +$15.5M | |
| 2 | +$4.16M | |
| 3 | +$3.17M | |
| 4 |
DM
Deerfield Management
New York
|
+$1.94M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$1.92M |
Top Sellers
| 1 | -$39.8M | |
| 2 | -$199K | |
| 3 | -$197K | |
| 4 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$138K |
| 5 |
JG
Jefferies Group
New York
|
-$115K |